Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques-Reference-Cited by-同舟云学术

Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques

Published:2020-04-24 Issue:10 Volume:9 Page:2000043
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv. Healthcare Mater.

Author:

Benne Naomi¹,Martins Cardoso Renata¹^ORCID,Boyle Aimee L.²^ORCID,Kros Alexander²^ORCID,Jiskoot Wim¹^ORCID,Kuiper Johan¹,Bouwstra Joke¹^ORCID,Van Eck Miranda¹,Slütter Bram¹^ORCID

Affiliation:

1. Division BioTherapeuticsLeiden Academic Centre for Drug ResearchLeiden University Leiden 2333CC The Netherlands

2. Department of Supramolecular and Biomaterials ChemistryLeiden Institute of ChemistryLeiden University Leiden 2333CC The Netherlands

Funder

Hartstichting

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202000043

Reference54 articles.

1. Immunity, atherosclerosis and cardiovascular disease

2. LOX-1, OxLDL, and Atherosclerosis

3. Mechanisms of foam cell formation in atherosclerosis

4. Macrophage death and defective inflammation resolution in atherosclerosis

5. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foam Cell Targeted Liposomes Co-Encapsulating Superoxide Dismutase and Catalase to Attenuate Atherosclerosis by Inhibiting Oxidative Stress;Discovery Medicine;2024

2. Nanomedicine for Diagnosis and Treatment of Atherosclerosis;Advanced Science;2023-10-28

3. Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual‐Track Reverse Cholesterol Transport Strategy;Small;2023-10-06

4. Liver X receptors: From pharmacology to nanoparticle-based drug delivery;European Journal of Pharmacology;2023-10

5. Potential role of Chinese medicine nanoparticles to treat coronary artery disease;Heliyon;2023-09